Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects
Clinical trial NCT01990846 · COMPLETED
Trial details
- NCT number
- NCT01990846
- Sponsor
- Autoimmune Technologies, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-02-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.